On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
This interactive workshop, led by renowned hepatologist Dr. Robert Gish, is designed to provide health care providers and their medical team with core medical knowledge of hepatitis B (HBV) and hepatitis C (HCV).
December 13 @ 2:00 pm - 3:00 pm EST
December 14 @ 9:00 am - 1:30 pm EST